Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin vs Insulin + Metformin for Gestational Diabetes
NCT03651531Phase 3Terminated
- Sponsor
- Women & Infants Hospital
- Start
- Jan 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM), sponsored by Women & Infants Hospital. Primary endpoint: Hemoglobin A1c. Started Jan 2018; status: terminated.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT03651531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651531.